WallStSmart

Morgan Stanley (MS)vsPJT Partners Inc (PJT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Morgan Stanley generates 4027% more annual revenue ($77.83B vs $1.89B). MS leads profitability with a 25.9% profit margin vs 10.6%. PJT appears more attractively valued with a PEG of 1.36. MS earns a higher WallStSmart Score of 75/100 (B).

MS

Strong Buy

75

out of 100

Grade: B

Growth: 9.3Profit: 8.0Value: 5.7Quality: 3.5
Piotroski: 5/9Altman Z: 0.38

PJT

Strong Buy

68

out of 100

Grade: B-

Growth: 8.7Profit: 8.5Value: 5.7Quality: 7.5
Piotroski: 5/9Altman Z: 3.08

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MS6 strengths · Avg: 9.2/10
Market CapQuality
$336.70B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
41.6%10/10

Strong operational efficiency at 41.6%

EPS GrowthGrowth
62.4%10/10

Earnings expanding 62.4% YoY

Profit MarginProfitability
25.9%9/10

Keeps 26 of every $100 in revenue as profit

P/E RatioValuation
17.3x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
28.0%8/10

Revenue surging 28.0% year-over-year

PJT5 strengths · Avg: 8.8/10
Return on EquityProfitability
68.4%10/10

Every $100 of equity generates 68 in profit

Altman Z-ScoreHealth
3.0810/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.0%8/10

Strong operational efficiency at 21.0%

Revenue GrowthGrowth
19.5%8/10

19.5% revenue growth

EPS GrowthGrowth
37.5%8/10

Earnings expanding 37.5% YoY

Areas to Watch

MS4 concerns · Avg: 2.3/10
PEG RatioValuation
1.874/10

Expensive relative to growth rate

Free Cash FlowQuality
$-3.57B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

Debt/EquityHealth
4.751/10

Elevated debt levels

PJT2 concerns · Avg: 3.5/10
Price/BookValuation
13.4x4/10

Trading at 13.4x book value

Debt/EquityHealth
1.343/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MS

The strongest argument for MS centers on Market Cap, Operating Margin, EPS Growth. Profitability is solid with margins at 25.9% and operating margin at 41.6%. Revenue growth of 28.0% demonstrates continued momentum.

Bull Case : PJT

The strongest argument for PJT centers on Return on Equity, Altman Z-Score, Operating Margin. Revenue growth of 19.5% demonstrates continued momentum. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bear Case : MS

The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.75 is elevated, increasing financial risk.

Bear Case : PJT

The primary concerns for PJT are Price/Book, Debt/Equity.

Key Dynamics to Monitor

MS carries more volatility with a beta of 1.21 — expect wider price swings.

MS is growing revenue faster at 28.0% — sustainability is the question.

PJT generates stronger free cash flow (226M), providing more financial flexibility.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MS scores higher overall (75/100 vs 68/100), backed by strong 25.9% margins and 28.0% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Morgan Stanley

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.

PJT Partners Inc

FINANCIAL SERVICES · CAPITAL MARKETS · USA

PJT Partners Inc., an investment bank, provides a variety of shareholder, restructuring and special situations, and capital market advisory services to corporations, financial backers, institutional investors and governments worldwide. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?